Multiple pregnancy rate · patients with endometriosis prior to standard IVF/ICSI
It is very uncertain whether long‐term GnRH agonist therapy changes multiple pregnancy rate compared with no additional therapy (very low certainty).
1 finding from 1 review
Miscarriage · patients with endometriosis prior to standard IVF/ICSI
It is very uncertain whether long‐term GnRH agonist therapy changes miscarriage rate compared with no additional therapy (very low certainty).
1 finding from 1 review
Number of oocytes retrieved · patients with endometriosis prior to standard IVF/ICSI
1 finding from 1 review
Mean number of embryos · patients with endometriosis prior to standard IVF/ICSI
1 finding from 1 review
Activities of daily living · older adults living in long‐term residential care including, but not limited to, dementia‐specific care settings
1 finding from 1 review
no estimate extracted
499 participants
Very low
ADL outcome · rehabilitation (long‐term outcomes)
1 finding from 1 review
Activity measures of the lower limb (lower limb activity) · rehabilitation (long‐term outcomes)
1 finding from 1 review
Motor impairment measures of the upper limb (upper limb impairment) · rehabilitation (long‐term outcomes)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Motor impairment measures of the lower limb (lower limb impairment) · rehabilitation (long‐term outcomes)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events/death: long‐term outcomes ‐ not reported · rehabilitation (long‐term outcomes)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Leaving the study early · people with both severe mental illness and substance misuse
RISPERIDONE showed no clear difference in leaving the study early: 1. any reason, long term (>12 months) compared with QUETIAPINE ‒ short‐ and long‐term data (low certainty).
1 finding from 1 review
No clinically important changes in specific symptoms ‐ positive and negative symptoms of schizophrenia (long term) Mental state: Not improved ‐ by 2 years ‐ as measured by PEF scale PEF scale · patients with people with severe mental illnesses
It is very uncertain whether SHORT changes no clinically important changes in specific symptoms ‐ positive and… compared with LONG HOSPITAL STAY (very low certainty).
1 finding from 1 review
Patient readmissions · patients with people with severe mental illnesses
SHORT showed no clear difference in service outcomes: 1a. Readmission to hospital (homogeneous studies)… compared with LONG HOSPITAL STAY (low certainty).
1 finding from 1 review
Leaving the study early · patients with people with severe mental illnesses
SHORT showed no clear difference in leaving the study early (long term) Participants leaving the study… compared with LONG HOSPITAL STAY (low certainty).
1 finding from 1 review
Clinician‐reported signs of eczema · people with eczema
1 finding from 1 review
Patient‐reported symptoms of eczema · people with eczema
1 finding from 1 review
Adverse effects: local · people with eczema
1 finding from 1 review
Systemic adverse events at · people with eczema
1 finding from 1 review
Change in quality of life · addition to tiotropium versus either tiotropium or LABA alone for chronic obstructive pulmonary disease
1 finding from 1 review
Quality of life SGRQ responder analysis at 6 months · addition to tiotropium versus either tiotropium or LABA alone for chronic obstructive pulmonary disease
Long‐acting beta2‐agonist plus tiotropium probably leads to higher quality of life SGRQ responder analysis at 6 months compared with tiotropium alone (moderate certainty).
1 finding from 1 review